How has Deborah Rathjen's remuneration changed compared to Bioasis Technologies's earnings?
Date
Total Compensation
Salary
Company Earnings
Nov 30 2022
n/a
n/a
-CA$3m
Aug 31 2022
n/a
n/a
-CA$3m
May 31 2022
n/a
n/a
-CA$3m
Feb 28 2022
CA$307k
CA$209k
-CA$3m
Nov 30 2021
n/a
n/a
-CA$3m
Aug 31 2021
n/a
n/a
-CA$1m
May 31 2021
n/a
n/a
CA$1m
Feb 28 2021
CA$268k
CA$190k
CA$698k
Nov 30 2020
n/a
n/a
CA$754k
Aug 31 2020
n/a
n/a
-CA$494k
May 31 2020
n/a
n/a
-CA$4m
Feb 29 2020
CA$282k
CA$192k
-CA$4m
Nov 30 2019
n/a
n/a
-CA$4m
Aug 31 2019
n/a
n/a
-CA$4m
May 31 2019
n/a
n/a
-CA$3m
Feb 28 2019
CA$105k
n/a
-CA$3m
Nov 30 2018
n/a
n/a
-CA$5m
Aug 31 2018
n/a
n/a
-CA$6m
May 31 2018
n/a
n/a
-CA$6m
Feb 28 2018
CA$283k
n/a
-CA$5m
Compensation vs Market: Insufficient data to establish whether Deborah's total compensation is reasonable compared to companies of similar size in the Canadian market.
Compensation vs Earnings: Insufficient data to compare Deborah's compensation with company performance.
CEO
Deborah Rathjen (66 yo)
5.3yrs
Tenure
CA$306,657
Compensation
Dr. Deborah Ann Rathjen, B.Sc. (Hons.), Ph D., M.A.I.C.D., FTSE, Q.C. has been the President and Chief Executive Officer of Bioasis Technologies Inc. since March 11, 2019. Dr. Rathjen served as the Chief E...
Board Members
Name
Position
Tenure
Compensation
Ownership
Deborah Rathjen
Executive Chairman
6.8yrs
CA$306.66k
0.22% CA$ 892.9
David Wurzer
Independent Lead Director
6yrs
CA$93.60k
0.067% CA$ 267.9
Jeffrey Cummings
Member of Scientific Advisory Board
6.8yrs
no data
no data
John Wikswo
Member of Scientific Advisory Board
6.8yrs
no data
no data
John Krystal
Chairman of Scientific Advisory Board
6.8yrs
no data
no data
Mario Saltarelli
Independent Non-Executive Director
5.2yrs
CA$93.60k
no data
Hope Rugo
Member of Medical Oncology Advisory Board
4.6yrs
no data
no data
John Hoppin
Member of Scientific Advisory Board
6.1yrs
no data
no data
John de Groot
Member of Medical Oncology Advisory Board
4.6yrs
no data
no data
Sue O'Connor
Member of Scientific Advisory board
6.1yrs
no data
no data
John Curran
Independent Director
6yrs
CA$93.60k
0.067% CA$ 267.5
Javier Cortés
Member of Medical Oncology Advisory Board
4.6yrs
no data
no data
6.0yrs
Average Tenure
66yo
Average Age
Experienced Board: BTI.H's board of directors are considered experienced (6 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2024/07/30 11:01
End of Day Share Price
2024/07/26 00:00
Earnings
2022/11/30
Annual Earnings
2022/02/28
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Bioasis Technologies Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.